Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-02
DOI
10.1038/s41375-021-01333-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
- (2021) Janine Stutterheim et al. JOURNAL OF CLINICAL ONCOLOGY
- Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia
- (2020) Hiroo Ueno et al. Blood Advances
- PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
- (2019) Zhaohui Gu et al. NATURE GENETICS
- NUTM1 is a recurrent fusion gene partner in B cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2
- (2019) Femke M Hormann et al. HAEMATOLOGICA
- Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
- (2019) Rob Pieters et al. JOURNAL OF CLINICAL ONCOLOGY
- Cryptic recurrent ACIN1 ‐ NUTM1 fusions in non‐ KMT2A ‐rearranged infant acute lymphoblastic leukemia
- (2019) Thomas Pincez et al. GENES CHROMOSOMES & CANCER
- Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)
- (2018) Martin Schrappe et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
- (2018) Jian-Feng Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group
- (2016) Rob Pieters et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
- (2016) Zhaohui Gu et al. Nature Communications
- The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
- (2015) Anna K Andersson et al. NATURE GENETICS
- BLUEPRINT: mapping human blood cell epigenomes
- (2013) J. H. A. Martens et al. HAEMATOLOGICA
- Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements
- (2013) P De Lorenzo et al. LEUKEMIA
- Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains
- (2010) Nicolas Reynoird et al. EMBO JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now